Lupin said the Food and Drug Administration approved its drug used to treat hyperkalemia. The Indian biopharmaceutical company said Monday its new drug application was approved for Sodium Zirconium ...

'My father placed his $600,000 Wisconsin home into a revocable trust, naming my brother as beneficiary' "If my niece and her mother continue living in the home, are there any special tax or trust ...

China was only a small destination for U.S. grain exports through the prior week, leaving soybean totals below the pace of last year. In the latest weekly Grain Export Inspections report from the ...

WINNIPEG, Manitoba--Canola futures on the Intercontinental Exchange rallied for the fourth straight session Monday, with the November contract exceeding its 20-day average. Crude oil prices gained ...

Provided by Business Wire Aug 9, 2026, 9:24:00 PM ...

What's going on with the job hunt these days? The share of Americans who are working or looking for a job hasn't been this low since the pandemic, according to a July jobs report full of gut punches.

Funds offering Main Street investors access to private markets are instead being used by professional money managers-in some cases, for access to hot IPOs. Revolut Secures French Banking License to ...

SpaceX shares have been clawing their way back in recent days but remain well off their highs SpaceX shares went public in June. It's been a volatile two months of trading for the stock since then.

'She was a teacher at a school district, so didn't put much into Social Security' If your wife expects to live beyond 75, it makes more sense for her to wait until FRA to claim her own Social Security ...

Vertex Pharmaceuticals shares rose after rival Sionna Therapeutics said a midstage trial of its cystic-fibrosis treatment failed to meet its primary endpoint, sending Sionna shares tumbling. Shares of ...

If SpaceX provides the compute capacity, Microsoft could monetize it. Elon Musk made some very big predictions and threw around some very big numbers during the SpaceX earnings call last week.

Just like memory went from an afterthought to AI's biggest bottleneck, the next boom could be in stocks of companies collecting recurring revenue from AI workloads The next boom could be in stocks of ...